相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC
Piotr Ponikowski et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Roles of phosphodiesterases in the regulation of the cardiac cyclic nucleotide cross-talk signaling network
Claire Y. Zhao et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
Animal models of heart failure with preserved ejection fraction
G. Conceicao et al.
NETHERLANDS HEART JOURNAL (2016)
The role of titin and extracellular matrix remodelling in heart failure with preserved ejection fraction
C. Franssen et al.
NETHERLANDS HEART JOURNAL (2016)
Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction
Constantijn Franssen et al.
JACC-HEART FAILURE (2016)
The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus
Csaba Matyas et al.
CARDIOVASCULAR DIABETOLOGY (2015)
PDE5 inhibitors as therapeutics for heart disease, diabetes and cancer
Anindita Das et al.
PHARMACOLOGY & THERAPEUTICS (2015)
An Altered Pattern of Myocardial Histopathological and Molecular Changes Underlies the Different Characteristics of Type-1 and Type-2 Diabetic Cardiac Dysfunction
Tamas Radovits et al.
JOURNAL OF DIABETES RESEARCH (2015)
Chronic inhibition of phosphodiesterase 5 with tadalafil attenuates mitochondrial dysfunction in type 2 diabetic hearts: potential role of NO/SIRT1/PGC-1α signaling
Saisudha Koka et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2014)
Regulation of SERCA pumps expression in diabetes
Angel Zarain-Herzberg et al.
CELL CALCIUM (2014)
Diabetic cardiomyopathy: Mechanisms and new treatment strategies targeting antioxidant signaling pathways
Karina Huynh et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Rat model of exercise-induced cardiac hypertrophy: hemodynamic characterization using left ventricular pressure-volume analysis
Tamas Radovits et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
Myocardial Titin Hypophosphorylation Importantly Contributes to Heart Failure With Preserved Ejection Fraction in a Rat Metabolic Risk Model
Nazha Hamdani et al.
CIRCULATION-HEART FAILURE (2013)
Vascular dysfunction induced by hypochlorite is improved by the selective phosphodiesterase-5-inhibitor vardenafil
Tamas Radovits et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction A Randomized Clinical Trial
Margaret M. Redfield et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Heart Failure with Preserved Ejection Fraction: Emerging Drug Strategies
Fouad A. Zouein et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2013)
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction Comorbidities Drive Myocardial Dysfunction and Remodeling Through Coronary Microvascular Endothelial Inflammation
Walter J. Paulus et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Chronic Inhibition of cGMP Phosphodiesterase 5A Improves Diabetic Cardiomyopathy A Randomized, Controlled Clinical Trial Using Magnetic Resonance Imaging With Myocardial Tagging
Elisa Giannetta et al.
CIRCULATION (2012)
Low Myocardial Protein Kinase G Activity in Heart Failure With Preserved Ejection Fraction
Loek van Heerebeek et al.
CIRCULATION (2012)
Defects in oxygen supply to skeletal muscle of prediabetic ZDF rats
Christopher G. Ellis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2010)
Hemodynamic effects of inducible nitric oxide synthase inhibition combined with sildenafil during acute pulmonary embolism
Carlos A. Dias-Junior et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2010)
The phosphodiesterase-5 inhibitor vardenafil improves cardiovascular dysfunction in experimental diabetes mellitus
T. Radovits et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Vardenafil protects against myocardial and endothelial injuries after cardiopulmonary bypass
Gabor Szabo et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2009)
Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy
Sophie Van Linthout et al.
BASIC RESEARCH IN CARDIOLOGY (2008)
Effects of Selective Phosphodiesterase-5-Inhibition on Myocardial Contractility and Reperfusion Injury After Heart Transplantation
Sivakkanan Loganathan et al.
TRANSPLANTATION (2008)
Nitric oxide and peroxynitrite in health and disease
Pal Pacher et al.
PHYSIOLOGICAL REVIEWS (2007)
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
E Takimoto et al.
NATURE MEDICINE (2005)
Cardioprotection with phosphodiesterase-5 inhibition - a novel preconditioning strategy
RC Kukreja et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2004)
Potency, selectivity, and consequences of nonselectivity of PDE inhibition
E Bischoff
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH (2004)
分享论文
